Related Experiment Video
Updated: Aug 3, 2025

Isolation of Functional Cardiac Immune Cells
Published on: December 5, 2011
Pathophysiological Effects of Various Interleukins on Primary Cell Types in Common Heart Disease
Yong Liu1,2, Donghui Zhang1,2, Dan Yin1,2
1State Key Laboratory of Biocatalysis and Enzyme Engineering, School of Life Science, Hubei University, Wuhan 430062, China.
Insights
This review explores how interleukins impact heart disease by affecting specific heart cells. Understanding these interleukin pathways could lead to more targeted and effective heart disease therapies.
Area of Science:
- Cardiovascular Biology
- Immunology
- Cellular Pathophysiology
Background:
- Common heart diseases like myocardial infarction and heart failure lack effective therapies due to complex pathogenesis.
- Cardiomyocytes, fibroblasts, endothelial cells, and immune cells are key players in heart disorders.
- The specific roles of interleukins and their pathways in these primary heart cells are not well understood.
Purpose of the Study:
- To review the pathophysiological effects of various interleukins on primary cell types in common heart diseases.
- To elucidate the complex roles of interleukins in cardiovascular disease.
- To provide insights for developing more precise and effective heart disease treatments.
Main Methods:
- Literature review focusing on interleukins and their effects on cardiomyocytes, fibroblasts, endothelial cells, and immune cells.
- Analysis of pathophysiological pathways involving specific interleukins in heart disease models.
- Synthesis of current knowledge on interleukin functions in cardiovascular contexts.
Main Results:
- Interleukins, including the IL-1 family, IL-2, IL-4, IL-6 family, IL-8, IL-10, and IL-17, exhibit diverse effects on different cardiac cell types.
- Specific interleukin actions can promote or inhibit disease progression depending on the cell type and context.
- The complex interplay between interleukins and cardiac cells contributes significantly to heart disease pathogenesis.
Conclusions:
- Targeting specific cell types with tailored interleukin-modulating therapies holds promise for treating heart disease.
- Further research into interleukin-specific cellular mechanisms is crucial for advancing cardiovascular medicine.
- A deeper understanding of these pathways can lead to novel therapeutic strategies for myocardial infarction, heart failure, and other cardiac conditions.
Abstract:
Myocardial infarction (MI), heart failure, cardiomyopathy, myocarditis, and myocardial ischemia-reperfusion injury (I/R) are the most common heart diseases, yet there is currently no effective therapy due to their complex pathogenesis. Cardiomyocytes (CMs), fibroblasts (FBs), endothelial cells (ECs), and immune cells are the primary cell types involved in heart disorders, and, thus, targeting a specific cell type for the treatment of heart disease may be more effective. The same interleukin may have various effects on different kinds of cell types in heart disease, yet the exact role of interleukins and their pathophysiological pathways on primary cell types remain largely unexplored. This review will focus on the pathophysiological effects of various interleukins including the IL-1 family (IL-1, IL-18, IL-33, IL-37), IL-2, IL-4, the IL-6 family (IL-6 and IL-11), IL-8, IL-10, IL-17 on primary cell types in common heart disease, which may contribute to the more precise and effective treatment of heart disease.
Related Concept Videos
Myocarditis I: Introduction
Pathophysiology of Heart Failure
Heart Failure II: Pathophysiology
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Layers of the Heart Wall
The myocardium, the thickest layer, consists of cardiac muscle cells interconnected by intercalated discs and crisscrossing connective tissue fibers. These muscle fibers contract...
Rheumatic Heart Disease I: Introduction

